White Paper

A Big Difference In Supply Chain Management Using Little's Law

Source: Kymanox Corporation

Maintaining a robust, reliable supply chain is crucial for companies manufacturing cell and gene therapies (CGTs) to reduce risk of delays and ensure the stability and efficacy of time and temperature sensitive materials. Supply chain disruptions over the past years and the CGT industry’s reliance on a combination of single use products and stainless steel, complex manufacturing practices, and regulatory complexity create unique demands when compared to other industries.

Monitoring the product shelf life, necessary testing, validation, and regulatory requirements for CGT products requires a coordinated effort from supply chain personnel and quality assurance associates. Utilizing a proactive solution such as Little’s Law can help teams to avoid costly delays and streamline the supply chain management process. However, the limitations common to Little’s Law often require the expertise of a supply chain professional to enable a tailored approach for different warehouses. Learn how leveraging Little’s Law to quantify metrics that otherwise would be causing confusion and process interruption can help to reduce wait time and deliver materials on-time and within budget.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader